Literature DB >> 22766971

Prevention or acceleration of type 1 diabetes by viruses.

Liana Ghazarian1, Julien Diana, Yannick Simoni, Lucie Beaudoin, Agnès Lehuen.   

Abstract

Type 1 diabetes is an autoimmune disease characterized by the destruction of insulin-producing pancreatic β-cells. Even though extensive scientific research has yielded important insights into the immune mechanisms involved in pancreatic β-cell destruction, little is known about the events that trigger the autoimmune process. Recent epidemiological and experimental data suggest that environmental factors are involved in this process. In this review, we discuss the role of viruses as an environmental factor on the development of type 1 diabetes, and the immune mechanisms by which they can trigger or protect against this pathology.

Entities:  

Mesh:

Year:  2012        PMID: 22766971     DOI: 10.1007/s00018-012-1042-1

Source DB:  PubMed          Journal:  Cell Mol Life Sci        ISSN: 1420-682X            Impact factor:   9.261


  185 in total

1.  Increased level of interferon-alpha in blood of patients with insulin-dependent diabetes mellitus: relationship with coxsackievirus B infection.

Authors:  W Chehadeh; J Weill; M C Vantyghem; G Alm; J Lefèbvre; P Wattré; D Hober
Journal:  J Infect Dis       Date:  2000-06-05       Impact factor: 5.226

2.  Variation in consumption of cow milk proteins and lower incidence of Type 1 diabetes in Iceland vs the other 4 Nordic countries.

Authors:  B E Birgisdottir; J P Hill; D P Harris; I Thorsdottir
Journal:  Diabetes Nutr Metab       Date:  2002-08

3.  No evidence for an association of coxsackie virus infections during pregnancy and early childhood with development of islet autoantibodies in offspring of mothers or fathers with type 1 diabetes.

Authors:  M Füchtenbusch; A Irnstetter; G Jäger; A G Ziegler
Journal:  J Autoimmun       Date:  2001-12       Impact factor: 7.094

4.  Molecular mimicry in type 1 diabetes: immune cross-reactivity between islet autoantigen and human cytomegalovirus but not Coxsackie virus.

Authors:  B O Roep; H S Hiemstra; N C Schloot; R R P De Vries; A Chaudhuri; P O Behan; J W Drijfhout
Journal:  Ann N Y Acad Sci       Date:  2002-04       Impact factor: 5.691

5.  Cellular immunity to a determinant common to glutamate decarboxylase and coxsackie virus in insulin-dependent diabetes.

Authors:  M A Atkinson; M A Bowman; L Campbell; B L Darrow; D L Kaufman; N K Maclaren
Journal:  J Clin Invest       Date:  1994-11       Impact factor: 14.808

6.  NKT cell-plasmacytoid dendritic cell cooperation via OX40 controls viral infection in a tissue-specific manner.

Authors:  Julien Diana; Thibault Griseri; Sylvie Lagaye; Lucie Beaudoin; Elodie Autrusseau; Anne-Sophie Gautron; Céline Tomkiewicz; André Herbelin; Robert Barouki; Matthias von Herrath; Marc Dalod; Agnès Lehuen
Journal:  Immunity       Date:  2009-02-12       Impact factor: 31.745

7.  Prevalence of Celiac disease among children in Finland.

Authors:  Markku Mäki; Kirsi Mustalahti; Jorma Kokkonen; Petri Kulmala; Mila Haapalahti; Tuomo Karttunen; Jorma Ilonen; Kaija Laurila; Ingrid Dahlbom; Tony Hansson; Peter Höpfl; Mikael Knip
Journal:  N Engl J Med       Date:  2003-06-19       Impact factor: 91.245

8.  Interferon-alpha initiates type 1 diabetes in nonobese diabetic mice.

Authors:  Qing Li; Baohui Xu; Sara A Michie; Kathleen H Rubins; Robert D Schreriber; Hugh O McDevitt
Journal:  Proc Natl Acad Sci U S A       Date:  2008-08-20       Impact factor: 11.205

9.  Serological evaluation of the role of cytomegalovirus in the pathogenesis of IDDM: a prospective study. The Childhood Diabetes in Finland Study Group.

Authors:  M Hiltunen; H Hyöty; J Karjalainen; P Leinikki; M Knip; R Lounamaa; H K Akerblom
Journal:  Diabetologia       Date:  1995-06       Impact factor: 10.122

10.  Innate immunity and intestinal microbiota in the development of Type 1 diabetes.

Authors:  Li Wen; Ruth E Ley; Pavel Yu Volchkov; Peter B Stranges; Lia Avanesyan; Austin C Stonebraker; Changyun Hu; F Susan Wong; Gregory L Szot; Jeffrey A Bluestone; Jeffrey I Gordon; Alexander V Chervonsky
Journal:  Nature       Date:  2008-09-21       Impact factor: 49.962

View more
  22 in total

Review 1.  Enterovirus and type 1 diabetes: What is the matter?

Authors:  Carla Sanchez Bergamin; Sergio Atala Dib
Journal:  World J Diabetes       Date:  2015-06-25

2.  Viruses and the Microbiota.

Authors:  Christopher M Robinson; Julie K Pfeiffer
Journal:  Annu Rev Virol       Date:  2014       Impact factor: 10.431

3.  A preclinical study on the efficacy and safety of a new vaccine against Coxsackievirus B1 reveals no risk for accelerated diabetes development in mouse models.

Authors:  Pär G Larsson; Tadepally Lakshmikanth; Olli H Laitinen; Renata Utorova; Stella Jacobson; Maarit Oikarinen; Erna Domsgen; Minni R L Koivunen; Pascal Chaux; Nicolas Devard; Valerie Lecouturier; Jeffrey Almond; Mikael Knip; Heikki Hyöty; Malin Flodström-Tullberg
Journal:  Diabetologia       Date:  2014-11-05       Impact factor: 10.122

Review 4.  The Role of the Intestinal Microbiome in Type 1 Diabetes Pathogenesis.

Authors:  James C Needell; Danny Zipris
Journal:  Curr Diab Rep       Date:  2016-10       Impact factor: 4.810

5.  Expression of the enteroviral capsid protein VP1 in the islet cells of patients with type 1 diabetes is associated with induction of protein kinase R and downregulation of Mcl-1.

Authors:  S J Richardson; P Leete; A J Bone; A K Foulis; N G Morgan
Journal:  Diabetologia       Date:  2012-10-14       Impact factor: 10.122

6.  Previous maternal infection protects offspring from enterovirus infection and prevents experimental diabetes development in mice.

Authors:  P G Larsson; T Lakshmikanth; E Svedin; C King; M Flodström-Tullberg
Journal:  Diabetologia       Date:  2013-01-24       Impact factor: 10.122

Review 7.  Type 1 diabetes genetic susceptibility and dendritic cell function: potential targets for treatment.

Authors:  Chie Hotta-Iwamura; Kristin V Tarbell
Journal:  J Leukoc Biol       Date:  2016-01-20       Impact factor: 4.962

Review 8.  Viral infections in type 1 diabetes mellitus--why the β cells?

Authors:  Anne Op de Beeck; Decio L Eizirik
Journal:  Nat Rev Endocrinol       Date:  2016-03-29       Impact factor: 43.330

Review 9.  Mining the Virome for Insights into Type 1 Diabetes.

Authors:  Arnold Park; Guoyan Zhao
Journal:  DNA Cell Biol       Date:  2018-03-13       Impact factor: 3.311

10.  CaV1.2 and CaV1.3 channel hyperactivation in mouse islet β cells exposed to type 1 diabetic serum.

Authors:  Guang Yang; Yue Shi; Jia Yu; Yuxin Li; Lina Yu; Andrea Welling; Franz Hofmann; Jörg Striessnig; Lisa Juntti-Berggren; Per-Olof Berggren; Shao-Nian Yang
Journal:  Cell Mol Life Sci       Date:  2014-10-08       Impact factor: 9.261

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.